SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068297
Filing Date
2024-08-13
Accepted
2024-08-13 16:30:35
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210146-10q_pasithea.htm   iXBRL 10-Q 677404
2 CERTIFICATION ea021014601ex31-1_pasi.htm EX-31.1 11363
3 CERTIFICATION ea021014601ex31-2_pasi.htm EX-31.2 11350
4 CERTIFICATION ea021014601ex32-1_pasi.htm EX-32.1 4516
5 CERTIFICATION ea021014601ex32-2_pasi.htm EX-32.2 4769
  Complete submission text file 0001213900-24-068297.txt   4568896

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ktta-20240630.xsd EX-101.SCH 44012
7 XBRL CALCULATION FILE ktta-20240630_cal.xml EX-101.CAL 35265
8 XBRL DEFINITION FILE ktta-20240630_def.xml EX-101.DEF 221548
9 XBRL LABEL FILE ktta-20240630_lab.xml EX-101.LAB 410037
10 XBRL PRESENTATION FILE ktta-20240630_pre.xml EX-101.PRE 221259
70 EXTRACTED XBRL INSTANCE DOCUMENT ea0210146-10q_pasithea_htm.xml XML 513540
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 241202158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)